Skip to main content
Caplight Logo









Primoris International Co., Ltd.

Primoris International Co., Ltd.

Private
SeoulHealthcare & Life Scienceshttp://www.primoris.co.kr

Last Round

Pre Seed

Feb 2, 2021

Total Funding Raised

$2.69M

Company Overview

Primoris International Co., Ltd. is a biotechnology company that develops and manufactures cosmetic and medical aesthetic products based on stem cell and exosome technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Advanced Materials, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

exosomesstem cell technologymedical aestheticsdermacosmeticscosmetic ingredientsskin regenerationanti-agingskin boostersK-beautyexosome therapyregenerative aestheticscosmeceuticalsumbilical cord blood stem cellsB2B cosmetic supplyexosome filleraesthetic medicineaesthetic devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Primoris International Co., Ltd. Comparables

Compare Primoris International Co., Ltd. with similar companies based on industry and business-model similarity.

Primoris International Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ExoCoBio
79%
Rion Aesthetics
77%
Kimera Labs
77%

Primoris International Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 2, 2021

Primoris International Co., Ltd. Investors

Notable investors and investment history

Primoris International Co., Ltd. investors
InvestorRounds
BNH INVESTMENTPre Seed
DAYLI PartnersPre Seed

Primoris International Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Primoris International Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Primoris International Co., Ltd.'s valuation, stock price, and market status.

Is Primoris International Co., Ltd. a public or private company?

Primoris International Co., Ltd. is a private company.

What is the current stock price of Primoris International Co., Ltd.?

Primoris International Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Primoris International Co., Ltd. worth (valuation)?

Valuation information for Primoris International Co., Ltd. is not publicly available.

Can I buy Primoris International Co., Ltd. stock?

Primoris International Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Primoris International Co., Ltd.'s last funding round?

Primoris International Co., Ltd.'s most recent funding round was Pre Seed on February 2, 2021.

Who are the main investors in Primoris International Co., Ltd.?

Key investors in Primoris International Co., Ltd. include BNH INVESTMENT, DAYLI Partners.

Will Primoris International Co., Ltd. IPO soon?

No public IPO plans have been announced for Primoris International Co., Ltd..

How can I track Primoris International Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Primoris International Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range2
Year Founded2017
Last FundingFeb 2, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?